Sign In
Buy AZYO
$1.49
+0 (+0%)
At Close: Dec 05, 2023
Aziyo Biologics, Inc. (AZYO) Reports Q1 Loss, Tops Revenue Estimates
06:48pm, Monday, 09'th May 2022
Aziyo Biologics, Inc. (AZYO) delivered earnings and revenue surprises of 3.23% and 6.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
09:45pm, Tuesday, 03'rd May 2022 Zacks Investment Research
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -14.84% and 2.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
08:05pm, Monday, 25'th Apr 2022 GlobeNewswire Inc.
SILVER SPRING, Md., April 25, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiate
Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
04:05pm, Monday, 25'th Apr 2022
SILVER SPRING, Md., April 25, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated
Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen
08:05pm, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
Call to Highlight the Use and Benefits of Aziyo’s CanGaroo Envelope for Implantable Electronic Devices Call to Highlight the Use and Benefits of Aziyo’s CanGaroo Envelope for Implantable Electroni
Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference
10:50pm, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
SILVER SPRING, Md., March 31, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiate
Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference
06:50pm, Thursday, 31'st Mar 2022
SILVER SPRING, Md., March 31, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated
Analysts Cut Price Target On Aziyo Biologics As Q4 Earnings Fall Short Of Expectations
02:28pm, Friday, 04'th Mar 2022 Benzinga
Aziyo Biologics Inc (NASDAQ: AZYO) Q4 FY21 sales decreased 13% to $10.9 million, missing the consensus of $11.06 million.
Excluding the contribution of FiberCel sales, which the product's distrib
Aziyo Biologics, Inc. (AZYO) Reports Q4 Loss, Lags Revenue Estimates
11:25pm, Thursday, 03'rd Mar 2022 Zacks Investment Research
Aziyo Biologics, Inc. (AZYO) delivered earnings and revenue surprises of -28.13% and 2.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stoc
Aziyo Biologics Reports Fourth Quarter and Full Year 2021 Financial Results
09:01pm, Thursday, 03'rd Mar 2022 GlobeNewswire Inc.
SILVER SPRING, Md., March 03, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiate
Aziyo Biologics, Inc. (AZYO) Reports Q4 Loss, Lags Revenue Estimates
07:55pm, Thursday, 03'rd Mar 2022
Aziyo Biologics, Inc. (AZYO) delivered earnings and revenue surprises of -28.13% and 2.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stoc
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q4 2021 Results - Earnings Call Transcript
07:55pm, Thursday, 03'rd Mar 2022
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q4 2021 Results - Earnings Call Transcript
Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference
09:01pm, Wednesday, 23'rd Feb 2022 GlobeNewswire Inc.
SILVER SPRING, Md., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated
Aziyo Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022
09:01pm, Thursday, 17'th Feb 2022 GlobeNewswire Inc.
SILVER SPRING, Md., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated
Aziyo Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022
04:01pm, Thursday, 17'th Feb 2022
SILVER SPRING, Md., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated p
